or search on
|Title:||Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality|
|Authors:||Canfell K; Sitas F; Beral V|
|Categories:||Early Detection, Diagnosis, and Prognosis - Resources and Infrastructure|
Cancer Type - Cervical Cancer
|Keywords:||Aged; mortality; New South Wales; Registries; Research; screening; Statistics; Wales; Women; analysis; Australia; cancer; cervical; Cervical Cancer; Design; epidemiology; Incidence|
|Journal Title:||Medical Journal of Australia|
|Page number start:||482|
|Page number end:||486|
|Abstract:||OBJECTIVE: To compare cervical screening policy, screening uptake, and changes in cervical cancer incidence and mortality between Australia and the United Kingdom. DESIGN: Analysis of screening registry data and national cancer statistics. SETTING: In Australia, organised cervical screening was initiated in 1991 for sexually active women aged 18-69 years, with a recommended 2-yearly interval. In the UK, organised screening began in 1988 for women aged 20-64 years, with a recommended 3-yearly interval in most regions. RESULTS: Estimated lifetime screening participation rates in 2001 were similar in the two countries, at 88% in Australia and 90% in the UK. For women who were screened and had a negative result, the median time to the next screen was 27 months in Australia and 38 months in the UK. At 39 months, equivalent proportions (74%) had been re-screened in the two countries, and by 60 months the re-screened proportions were 81% in Australia and 94% in the UK. From 1991-1993 to 1998-2000, the incidence of cervical cancer in women aged 20-69 years fell by 33% in Australia and 33% in the UK, and mortality from cervical cancer fell by 36% in both countries. CONCLUSIONS: After the introduction of organised screening, similar reductions in cervical cancer incidence and mortality were achieved in Australia and the UK. Therefore, the 2-yearly screening policy in Australia and the predominantly 3-yearly screening policy in the UK appear to have been of broadly similar effectiveness|
|Programme:||Epi Mod Screen|
|Division:||Cancer Research Division|
|Appears in Collections:||Research Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.